---
title: "昂瑞微-UW 为上海 IPO 定价，计划筹集最多 20.7 亿元人民币"
description: "OnMicro 定价上海首次公开募股，计划筹集高达 20.7 亿元人民币"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/268508131.md"
published_at: "2025-12-04T00:50:38.000Z"
---

# 昂瑞微-UW 为上海 IPO 定价，计划筹集最多 20.7 亿元人民币

> OnMicro 定价上海首次公开募股，计划筹集高达 20.7 亿元人民币

### Related Stocks

- [688790.CN - 昂瑞微-UW](https://longbridge.com/zh-CN/quote/688790.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Averin Capital Acquisition Closes IPO | Averin Capital Acquisition Closes IPO | [Link](https://longbridge.com/zh-CN/news/276488533.md) |
| iFOREX Announces Successful Pricing Of Its IPO At 195 Pence Per Ordinary Share | IFOREX FINANCIAL : IFOREX FINANCIAL - PROSPECTUS AND ANNOUNCEMENT OF OFFER PRICEIFOREX: ANNOUNCES SUCCESSFUL PRICING OF  | [Link](https://longbridge.com/zh-CN/news/276345476.md) |
| Liftoff announces confidential submission of draft registration statement for proposed IPO | Liftoff announces confidential submission of draft registration statement for proposed IPO | [Link](https://longbridge.com/zh-CN/news/276180047.md) |
| Averin Capital Acquisition Corp. Announces the Pricing of $250,000,000 Initial Public Offering \| ACAAU Stock News | Averin Capital Acquisition Corp. has priced its initial public offering at $250 million, offering 25 million units at $1 | [Link](https://longbridge.com/zh-CN/news/276276275.md) |
| Synthetic regenerative graft developer Medical 21 files for a $25 million IPO | Medical 21, a Minneapolis-based developer of synthetic regenerative grafts for CABG surgery, has filed with the SEC for  | [Link](https://longbridge.com/zh-CN/news/276343434.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。